News
1d
MedPage Today on MSNShould AMA 'Support' a Registry to Track Side Effects of GLP-1 Drugs?CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...
A WOMAN has shared how she lost a staggering 9.5 stone being on Mounjaro, but said there was a dark side that no one talks ...
2don MSN
Mounjaro is generally considered safe for use under medical supervision, especially for individuals who are overweight or ...
15hon MSN
People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...
Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as ...
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...
By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...
1don MSN
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...
WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...
Ozempic, a medication primarily prescribed for type 2 diabetes and obesity management, has gained popularity for its weight-loss benefits. However, some male users have reported u ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results